Patent · US Active

Thiadiazole IRAK4 inhibitors

US12060351B2 · kind B2 · utility

0Cited by
3References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 13, 2019
Grant dateAug 13, 2024
Priority date—
Expiry dateFeb 7, 2041

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A compound of Formula (I): pharmaceutically acceptable salts thereof, deuterated analogs thereof, compositions thereof, and methods of treating disease using a compound thereof are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.